PMC:7264098 / 11616-11825
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T223 | 28-37 | DG_29 | denotes | ribavirin |
T224 | 107-111 | SP_9 | denotes | MERS |
T4874 | 28-37 | DG_29 | denotes | ribavirin |
T72833 | 107-111 | SP_9 | denotes | MERS |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
272 | 28-37 | Chemical | denotes | ribavirin | MESH:D012254 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T119 | 127-131 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T37 | 28-37 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
T38 | 42-52 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T67 | 0-209 | Sentence | denotes | Although the combination of ribavirin and interferon-based (IFN) treatments appears the most effective for MERS (Morra et al., 2018), this needs to be confirmed in randomized placebo-controlled trial settings. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32574317-29664167-31466308 | 127-131 | 29664167 | denotes | 2018 |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32574317-29664167-31466308 | 127-131 | 29664167 | denotes | 2018 |